(R)-(3-Methyl-1-(pyrazine-2-carboxamido)butyl)boronic Acid is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. Molecular Formula: C10H16BN3O3 Molecular Weight: 237.06 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
237.06
* VAT and and shipping costs not included. Errors and price changes excepted